NASDAQ · Analyst Forecast

Marker Therapeutics, Inc. (MRKR) Stock Forecast & Price Target

$0.84 NASDAQ: MRKR Market Cap $13.95M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Marker Therapeutics, Inc. (MRKR), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Marker Therapeutics, Inc., analysts forecast revenue rising from $3.11M in 2025 to $325.47M in 2030; the average estimate for 2030 earnings per share is $5.23; with published estimates ranging from −$0.30 to $9.77; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$2.77M$3.11M$3.46M2
2026$2.83M$4.24M$5.66M2
2027$6.85M$20.19M$33.52M2
2028$5.70M$83.97M$146.20M3
2029$30.77M$164.62M$274.64M1
2030$60.83M$325.47M$542.99M2

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$0.86−$0.40$0.052
2026−$0.60−$0.59−$0.582
2027−$1.12−$0.88−$0.632
2028−$0.85$0.52$1.423
2029−$0.11$1.88$3.511
2030−$0.30$5.23$9.772

Marker Therapeutics, Inc. (MRKR) forecast — frequently asked questions

What are analysts forecasting for Marker Therapeutics, Inc.'s earnings?

The average analyst estimate for Marker Therapeutics, Inc. (MRKR) earnings per share in 2030 is 5.23, with individual estimates between -0.30 and 9.77.

How much revenue is Marker Therapeutics, Inc. expected to make?

Analysts forecast Marker Therapeutics, Inc. (MRKR) revenue of $325.47M in 2030, based on 2 published estimates.

How many analysts cover MRKR?

3 analysts contribute estimates for Marker Therapeutics, Inc. (MRKR). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.